Literature DB >> 30827466

Nucleoside analogs in the study of the epitranscriptome.

Cody M Palumbo1, Peter A Beal2.   

Abstract

Over 150 unique RNA modifications are now known including several nonstandard nucleotides present in the body of messenger RNAs. These modifications can alter a transcript's function and are collectively referred to as the epitrancriptome. Chemically modified nucleoside analogs are poised to play an important role in the study of these epitranscriptomic marks. Introduced chemical features on nucleic acid strands provide unique structures or reactivity that can be used for downstream detection or quantification. Three methods are used in the field to synthesize RNA containing chemically modified nucleoside analogs. Nucleoside analogs can be introduced by metabolic labeling, via polymerases with modified nucleotide triphosphates or via phosphoramidite-based chemical synthesis. In this review, these methods for incorporation of nucleoside analogs will be discussed with specific recently published examples pertaining to the study of the epitranscriptome.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADAR; Epitranscriptome; Inosine; Mettl3; Nucleoside analog; m(6)A

Mesh:

Substances:

Year:  2018        PMID: 30827466      PMCID: PMC6400310          DOI: 10.1016/j.ymeth.2018.10.014

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  73 in total

1.  Transcriptome-wide identification of A > I RNA editing sites by inosine specific cleavage.

Authors:  Pierre B Cattenoz; Ryan J Taft; Eric Westhof; John S Mattick
Journal:  RNA       Date:  2012-12-21       Impact factor: 4.942

2.  Structures of KlenTaq DNA polymerase caught while incorporating C5-modified pyrimidine and C7-modified 7-deazapurine nucleoside triphosphates.

Authors:  Konrad Bergen; Anna-Lena Steck; Stefan Strütt; Anna Baccaro; Wolfram Welte; Kay Diederichs; Andreas Marx
Journal:  J Am Chem Soc       Date:  2012-04-11       Impact factor: 15.419

3.  Precise Antibody-Independent m6A Identification via 4SedTTP-Involved and FTO-Assisted Strategy at Single-Nucleotide Resolution.

Authors:  Tingting Hong; Yushu Yuan; Zonggui Chen; Kun Xi; Tianlu Wang; Yalun Xie; Zhiyong He; Haomiao Su; Yu Zhou; Zhi-Jie Tan; Xiaocheng Weng; Xiang Zhou
Journal:  J Am Chem Soc       Date:  2018-03-05       Impact factor: 15.419

Review 4.  Functions and regulation of RNA editing by ADAR deaminases.

Authors:  Kazuko Nishikura
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

5.  Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.

Authors:  Gillian I Rice; Paul R Kasher; Gabriella M A Forte; Niamh M Mannion; Sam M Greenwood; Marcin Szynkiewicz; Jonathan E Dickerson; Sanjeev S Bhaskar; Massimiliano Zampini; Tracy A Briggs; Emma M Jenkinson; Carlos A Bacino; Roberta Battini; Enrico Bertini; Paul A Brogan; Louise A Brueton; Marialuisa Carpanelli; Corinne De Laet; Pascale de Lonlay; Mireia del Toro; Isabelle Desguerre; Elisa Fazzi; Angels Garcia-Cazorla; Arvid Heiberg; Masakazu Kawaguchi; Ram Kumar; Jean-Pierre S-M Lin; Charles M Lourenco; Alison M Male; Wilson Marques; Cyril Mignot; Ivana Olivieri; Simona Orcesi; Prab Prabhakar; Magnhild Rasmussen; Robert A Robinson; Flore Rozenberg; Johanna L Schmidt; Katharina Steindl; Tiong Y Tan; William G van der Merwe; Adeline Vanderver; Grace Vassallo; Emma L Wakeling; Evangeline Wassmer; Elizabeth Whittaker; John H Livingston; Pierre Lebon; Tamio Suzuki; Paul J McLaughlin; Liam P Keegan; Mary A O'Connell; Simon C Lovell; Yanick J Crow
Journal:  Nat Genet       Date:  2012-09-23       Impact factor: 38.330

6.  Large-scale overexpression and purification of ADARs from Saccharomyces cerevisiae for biophysical and biochemical studies.

Authors:  Mark R Macbeth; Brenda L Bass
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

7.  Human METTL16 is a N6-methyladenosine (m6A) methyltransferase that targets pre-mRNAs and various non-coding RNAs.

Authors:  Ahmed S Warda; Jens Kretschmer; Philipp Hackert; Christof Lenz; Henning Urlaub; Claudia Höbartner; Katherine E Sloan; Markus T Bohnsack
Journal:  EMBO Rep       Date:  2017-10-19       Impact factor: 8.807

8.  N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.

Authors:  Guifang Jia; Ye Fu; Xu Zhao; Qing Dai; Guanqun Zheng; Ying Yang; Chengqi Yi; Tomas Lindahl; Tao Pan; Yun-Gui Yang; Chuan He
Journal:  Nat Chem Biol       Date:  2011-10-16       Impact factor: 15.040

9.  A fly view on the roles and mechanisms of the m6A mRNA modification and its players.

Authors:  Tina Lence; Matthias Soller; Jean-Yves Roignant
Journal:  RNA Biol       Date:  2017-03-29       Impact factor: 4.652

10.  Differential Binding of Three Major Human ADAR Isoforms to Coding and Long Non-Coding Transcripts.

Authors:  Josephine Galipon; Rintaro Ishii; Yutaka Suzuki; Masaru Tomita; Kumiko Ui-Tei
Journal:  Genes (Basel)       Date:  2017-02-11       Impact factor: 4.096

View more
  3 in total

Review 1.  The Regulation of RNA Modification Systems: The Next Frontier in Epitranscriptomics?

Authors:  Matthias R Schaefer
Journal:  Genes (Basel)       Date:  2021-02-26       Impact factor: 4.096

2.  Amine-to-Azide Conversion on Native RNA via Metal-Free Diazotransfer Opens New Avenues for RNA Manipulations.

Authors:  Olga A Krasheninina; Julia Thaler; Matthias D Erlacher; Ronald Micura
Journal:  Angew Chem Int Ed Engl       Date:  2021-02-18       Impact factor: 15.336

Review 3.  Triazole-Modified Nucleic Acids for the Application in Bioorganic and Medicinal Chemistry.

Authors:  Dagmara Baraniak; Jerzy Boryski
Journal:  Biomedicines       Date:  2021-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.